Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Zorn · SciRah

Researcher profile · Semantic Scholar

K. Zorn

Share profile

K. Zorn — researcher profile on SciRah

h-index: 31
Works: 124
Citations: 9,505

Most-cited papers

Integrated Genomic Characterization of Endometrial Carcinoma
G. Getz, S. Gabriel, K. Cibulskis, E. Lander +268 more
2013Nature5,491 citations Open access
Semantic Scholar
Identification of twelve new susceptibility loci for different histotypes of epithelial ovarian cancer
C. Phelan, Karoline B. Kuchenbaecker, J. Tyrer, S. Kar +410 more
2017Nature Genetics399 citations Open access
Semantic Scholar
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
R. Milne, Karoline B. Kuchenbaecker, K. Michailidou, J. Beesley +466 more
2017Nature Genetics379 citations Open access
Semantic Scholar
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
Hao-Yu Zhang, T. Ahearn, J. Lecarpentier, D. Barnes +269 more
2019bioRxiv353 citations Open access
Semantic Scholar
Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations
T. Rebbeck, T. Friebel, E. Friedman, U. Hamann +238 more
2018Human Mutation299 citations Open access
Semantic Scholar
BRCA1/2 mutations and expression: response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer.
Rebecca Byler Dann, J. Deloia, K. Timms, K. Zorn +4 more
2012Gynecologic Oncology115 citations
Semantic Scholar
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
Valentina Silvestri, D. Barrowdale, A. Mulligan, S. Neuhausen +142 more
2016Breast Cancer Research111 citations Open access
Semantic Scholar
Shared heritability and functional enrichment across six solid cancers
Xia Jiang, H. Finucane, F. Schumacher, S. Schmit +329 more
2019Nature Communications104 citations Open access
Semantic Scholar
Epithelial ovarian cancer
K. Zorn, Ginger J. Gardner, Michael J. Birrer
2018An Atlas of Gynecologic Oncology81 citations
Semantic Scholar
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women
T. Rebbeck, T. Friebel, N. Mitra, F. Wan +99 more
2016Breast Cancer Research70 citations Open access
Semantic Scholar
A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk
Ying-Chang Lu, A. Beeghly-Fadiel, Lang Wu, Xing-Yi Guo +140 more
2018Cancer Research62 citations Open access
Semantic Scholar
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
C. Phelan, K. Kuchenbaecker, J. Tyrer, S. Kar +410 more
2017Nature Genetics62 citations Open access
Semantic Scholar
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Valentina Silvestri, Goska Leslie, D. Barnes, B. Agnarsson +119 more
2020JAMA Oncology59 citations Open access
Semantic Scholar
Polygenic risk modeling for prediction of epithelial ovarian cancer risk
E. Dareng, J. Tyrer, D. Barnes, Michelle R. Jones +263 more
2022European Journal of Human Genetics57 citations Open access
Semantic Scholar
Germline pathogenic variants identified in women with ovarian tumors.
Natalie J. Carter, M. Marshall, Lisa R. Susswein, K. Zorn +10 more
2018Gynecologic Oncology51 citations
Semantic Scholar
Occult uterine cancer in patients undergoing laparoscopic hysterectomy with morcellation
M. Rowland, J. Lesnock, R. Edwards, S. Richard +3 more
201243 citations
Semantic Scholar
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
G. Figlioli, M. Bogliolo, Irene Catucci, Laura Caleca +473 more
2019npj Breast Cancer41 citations Open access
Semantic Scholar
Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease?
M. Courtney-Brooks, P. Sukumvanich, S. Beriwal, K. Zorn +2 more
2010Gynecologic Oncology40 citations
Semantic Scholar
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
Juliette Coignard, M. Lush, J. Beesley, T. O'Mara +388 more
2021Nature Communications37 citations Open access
Semantic Scholar
Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era
J. Berger, Ashlee L. Smith, K. Zorn, P. Sukumvanich +3 more
2014OncoTargets and Therapy35 citations Open access
Semantic Scholar
The Female Self-Advocacy in Cancer Survivorship Scale: A Validation Study
T. Hagan, Susan M. Cohen, M. Rosenzweig, K. Zorn +2 more
2017Journal of Advanced Nursing32 citations Open access
Semantic Scholar
Use of Metformin in Obese Women With Type I Endometrial Cancer Is Associated With a Reduced Incidence of Cancer Recurrence
C. Hall, R. Stone, Ashita Gehlot, K. Zorn +1 more
2015International Journal of Gynecologic Cancer32 citations Open access
Semantic Scholar
Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications.
J. Lesnock, S. Richard, K. Zorn, T. Krivak +5 more
2010Gynecologic Oncology32 citations
Semantic Scholar
Definitive radiation therapy for endometrial cancer in medically inoperable elderly patients.
R. Wegner, S. Beriwal, D. Heron, S. Richard +5 more
2009Brachytherapy30 citations
Semantic Scholar
Phase II study of everolimus and bevacizumab in recurrent ovarian, peritoneal, and fallopian tube cancer.
Sarah E Taylor, T. Chu, J. Elvin, R. Edwards +1 more
2019Gynecologic Oncology29 citations
Semantic Scholar
Surgery Versus Radiation Therapy for Stage IB2 Cervical Carcinoma: A Population-Based Analysis
B. Rungruang, M. Courtney-Brooks, S. Beriwal, K. Zorn +4 more
2012International Journal of Gynecologic Cancer27 citations Open access
Semantic Scholar
A multidisciplinary clinic for individualizing management of patients at increased risk for breast and gynecologic cancer
N. Engel, P. Gordon, D. Thull, Beth Dudley +3 more
2012Familial Cancer27 citations
Semantic Scholar
Perspectives on Self-Advocacy: Comparing Perceived Uses, Benefits, and Drawbacks Among Survivors and Providers
T. Hagan, M. Rosenzweig, K. Zorn, G. V. van Londen +1 more
2017Oncology Nursing Forum26 citations Open access
Semantic Scholar
Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness
Vivek Patel, Evan L. Busch, T. Friebel, A. Cronin +259 more
2019Cancer Research21 citations Open access
Semantic Scholar
Heavy Cervical Cancer Burden in Elderly Women: How Can We Improve the Situation?
M. Skaznik-Wikiel, P. Sukumvanich, R. M. Austin, K. Zorn +3 more
2012Acta Cytologica21 citations
Semantic Scholar
Possible Use of CA-125 Level Normalization After the Third Chemotherapy Cycle in Deciding on Chemotherapy Regimen in Patients With Epithelial Ovarian Cancer: Brief Report
M. Skaznik-Wikiel, P. Sukumvanich, S. Beriwal, K. Zorn +3 more
2011International Journal of Gynecologic Cancer16 citations Open access
Semantic Scholar
Challenges in recruiting African-American women for a breast cancer genetics study
A. Compadre, M. Simonson, K. Gray, Gail A. Runnells +2 more
2018Hereditary Cancer in Clinical Practice15 citations Open access
Semantic Scholar
Intraperitoneal Chemotherapy for Recurrent Epithelial Ovarian Cancer Is Feasible With High Completion Rates, Low Complications, and Acceptable Patient Outcomes
M. Skaznik-Wikiel, J. Lesnock, W. Mcbee, S. Beriwal +4 more
2011International Journal of Gynecologic Cancer14 citations Open access
Semantic Scholar
Oxaliplatin salvage for recurrent ovarian cancer: a single institution's experience in patient populations with platinum resistant disease or a history of platinum hypersensitivity.
Sarah E Taylor, T. Beck, T. Krivak, K. Zorn +2 more
2014Gynecologic Oncology13 citations
Semantic Scholar
Novel Surgical Approaches for Sampling the Ovarian Surface Epithelium and Proximal Fluid Proteome
B. Rungruang, B. Hood, Mai Sun, E. Hoskins +2 more
2010Journal of Proteome Research12 citations Open access
Semantic Scholar
Recurrent gynandroblastoma of the ovary with germline DICER1 mutation: A case report and review of the literature
A. M. Mercier, K. Zorn, C. Quick, L. Huffman
2021Gynecologic Oncology Reports11 citations Open access
Semantic Scholar
Phase I study of intravenous oxaliplatin and intraperitoneal docetaxel in recurrent ovarian cancer
Sarah E Taylor, Jennifer S. Petschauer, H. Donovan, Allison N. Schorzman +4 more
2019International Journal of Gynecologic Cancer9 citations Open access
Semantic Scholar
Preoperative high dose rate brachytherapy for clinical stage II endometrial carcinoma
G. Shukla, S. Beriwal, T. Krivak, J. Kelley +5 more
2011Journal of Contemporary Brachytherapy9 citations Open access
Semantic Scholar
What’s in Between the Lines: Assessing the Readability, Understandability, and Actionability in Breast Cancer Survivorship Print Materials
Pearman D. Parker, A. Prabhu, L. Su, K. Zorn +3 more
2021Journal of Cancer Education8 citations Open access
Semantic Scholar
Occult uterine cancer in patients undergoing laparoscopic hysterectomy with morcellation: Implications for surveillance for disease recurrence and outcomes
M. Rowland, J. Lesnock, R. Edwards, S. Richard +3 more
20138 citations
Semantic Scholar
Metastatic Ovarian Serous Carcinoma Presenting as Inflammatory Breast Cancer: A Case Report
D. Gingell, Amber R. Samuel, Denise M. Haynik, W. Mcbee +3 more
2010International Journal of Gynecological Pathology8 citations
Semantic Scholar
Can Automated Alerts in the Electronic Health Record Encourage Referrals for Genetic Counseling and Testing Among Patients at High Risk for Hereditary Cancer Syndromes?
K. Zorn, M. Simonson, J. Faulkner, Cyndee L Carr +5 more
2022JCO Oncology Practice7 citations Open access
Semantic Scholar
Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian Cancer
M. Boisen, J. Lesnock, S. Richard, S. Beriwal +3 more
2016International Journal of Gynecologic Cancer7 citations Open access
Semantic Scholar
Extreme obesity does not predict poor cancer outcomes after surgery for renal cell cancer
M. Blute, K. Zorn, M. Grimes, F. Shi +6 more
2015BJU International7 citations Open access
Semantic Scholar
Publisher Correction: Shared heritability and functional enrichment across six solid cancers
Xia Jiang, H. Finucane, F. Schumacher, S. Schmit +329 more
2019Nature Communications6 citations Open access
Semantic Scholar
Phase II study of everolimus (EV) and bevacizumab (BEV) in recurrent ovarian, peritoneal, and fallopian tube cancer.
Sarah E Taylor, T. Chu, R. Edwards, K. Zorn
20166 citations
Semantic Scholar
Phase I study of intravenous (IV) docetaxel and intraperitoneal (IP) oxaliplatin in recurrent ovarian and fallopian tube cancer.
Sarah E Taylor, Ruo-Sha Li, Jennifer S. Petschauer, H. Donovan +5 more
2015Gynecologic Oncology6 citations
Semantic Scholar
PARP inhibition in epithelial ovarian cancer: high hopes undergo a reality check.
K. Zorn
2012Oncology6 citations
Semantic Scholar
A Critical Analysis of Perioperative Outcomes in Morbidly Obese Patients Following Renal Mass Surgery
M. Grimes, M. Blute, T. Wittmann, Michael A. Mann +8 more
2016Urology4 citations Open access
Semantic Scholar
The female self-advocacy in cancer survivorship scale: Validating a new measure to support patient voice and engagement.
T. Hagan, Susan M. Cohen, M. Rosenzweig, K. Zorn +2 more
2016Journal of Clinical Oncology3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. McGuffog×15
Invite
L. McGuffog — researcher profile on SciRah
I. Andrulis×15
Invite
I. Andrulis — researcher profile on SciRah
O. Díez×15
Invite
O. Díez — researcher profile on SciRah
U. Hamann×15
Invite
U. Hamann — researcher profile on SciRah

×15

Invite

M. Montagna — researcher profile on SciRah

S. Neuhausen×15

Invite

S. Neuhausen — researcher profile on SciRah

H. Nevanlinna×15

Invite

H. Nevanlinna — researcher profile on SciRah

Invite

O. Olopade — researcher profile on SciRah

Invite

M. Southey — researcher profile on SciRah

Invite

A. Toland — researcher profile on SciRah

Invite

N. Tung — researcher profile on SciRah

Invite

J. Weitzel — researcher profile on SciRah